Tempus AI is a leader in applying AI solutions to cancer diagnosis. The company announced a new platform for speeding up the ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

On Thursday’s episode of Mad Money, Jim Cramer voiced his exasperation over the skepticism surrounding AI infrastructure as ...

The validation study recently published in the Journal of Molecular Diagnostics Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and ...

The TIME Precision Network is a newly-formed group of investigators across TIME’s provider site network dedicated to supporting Phase I trials Tempus AI, Inc. (NASDAQ: TEM), a technology company ...

Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced publication of its study ...

In this video, I will talk about Tempus AI (NASDAQ: TEM) and whether it is worth buying after the recent pullback. Watch the ...

CHICAGO - Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine with a market capitalization of $9.15 billion, announced the launch of Tempus Loop, a new platform designed to enhance ...

BlackRock, Tempus, Sunrun, EXL Service, Union Pacific and VieMed Healthcare.